Send us Feedback

Elan Corporation (ELN)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

ELN » Topics » (g) Provisions related to sales made in prior periods

This excerpt taken from the ELN 20-F filed Feb 26, 2009.
(g) Provisions related to sales made in prior periods
 
During 2008, we recorded $2.7 million of adjustments to decrease the sales returns related to sales made in prior periods, primarily due to the availability of additional information relating to our actual returns experience for Maxipime and Azactam.
 
This excerpt taken from the ELN 20-F filed Feb 28, 2008.
(g) Provisions related to sales made in prior periods
 
During 2007, we recorded $0.4 million of adjustments to increase the discounts and allowances related to sales made in prior periods, primarily due to the availability of additional information relating to our actual returns experience for Tysabri, Maxipime and Azactam.
 
This excerpt taken from the ELN 20-F filed Feb 28, 2007.
(g) Provisions related to sales made in prior periods
 
During 2006, we recorded $1.7 million of adjustments to reduce the discounts and allowances related to sales made in prior periods, primarily due to the availability of additional information relating to our actual returns experience for Maxipime and Azactam.
 
This excerpt taken from the ELN 20-F filed Mar 30, 2006.
(g) Provisions related to sales made in prior periods
 
During 2005, we recorded $1.5 million of adjustments to reduce the discounts and allowances related to sales made in prior periods, primarily due to the availability of additional information relating to the impact of genericization of Zanaflextm (tizanidine hydrochloride).
 

EXCERPTS ON THIS PAGE:

20-F
Feb 26, 2009
20-F
Feb 28, 2008
20-F
Feb 28, 2007
20-F
Mar 30, 2006

RELATED TOPICS for ELN:

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki